TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹7,364 Cr |
| Mar2024 | ₹6,796 Cr |
| Mar2023 | ₹6,077 Cr |
| Mar2022 | ₹5,524 Cr |
| Mar2021 | ₹5,769 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,364 Cr | 8.36 | |
| Mar2024 | ₹6,796 Cr | 11.84 | |
| Mar2023 | ₹6,077 Cr | 10.00 | |
| Mar2022 | ₹5,524 Cr | -4.24 | |
| Mar2021 | ₹5,769 Cr | - | |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹129,284.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,885.2 Cr | -3.5% | -4.4% | -25.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0% |
2.7% |
11% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses